Advertisement

Acta Parasitologica

, Volume 60, Issue 2, pp 179–189 | Cite as

Antiparasitic DNA vaccines in 21st century

  • Halina WedrychowiczEmail author
Invited Review

Abstract

Demands for effective vaccines to control parasitic diseases of humans and livestock have been recently exacerbated by the development of resistance of most pathogenic parasites to anti-parasitic drugs. Novel genomic and proteomic technologies have provided opportunities for the discovery and improvement of DNA vaccines which are relatively easy as well as cheap to fabricate and stable at room temperatures. However, their main limitation is rather poor immunogenicity, which makes it necessary to couple the antigens with adjuvant molecules. This paper review recent advances in the development of DNA vaccines to some pathogenic protozoa and helminths. Numerous studies were conducted over the past 14 years of 21st century, employing various administration techniques, adjuvants and new immunogenic antigens to increase efficacy of DNA vaccines. Unfortunately, the results have not been rewarding. Further research is necessary using more extensive combinations of antigens; alternate delivery systems and more efficient adjuvants based on knowledge of the immunomodulatory capacities of parasitic protozoa and helminths.

Keywords

DNA vaccines adjuvants exprimental trials immunomodulation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahmad G., Torren W., Zhang W., Wyatt M., Siddiqui A.A. 2009a. Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni. Parasite Immunology, 31, 156–161. DOI: 10.1111/j.1365-3024.2008.001091.xPubMedPubMedCentralCrossRefGoogle Scholar
  2. Ahmad G., Zhang W., Torben W., Damian R.T., Chavez-Suarez M., Wolf R.F., White G.L. 2009b. Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model. Vaccine, 27, 2830–2837. DOI: 10.1016/j.vaccine.2009.02.096PubMedPubMedCentralCrossRefGoogle Scholar
  3. Ahmad G., Zhang W., Torben W., Haskins C., Diggs S., Noor Z., Le L., Siddiqui A.A. 2009c Prime/boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine. Parasitology Research, 105, 1767–1777. DOI: 10.1007/s00436-009-1646-zPubMedPubMedCentralCrossRefGoogle Scholar
  4. Anand S.B., Murugan V., Prabhu P.R., Anandharaman V., Reddy M.V., Kaliraj P. 2008. Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) inmice. Acta Tropica, 107, 106–112PubMedCrossRefGoogle Scholar
  5. Anand S.B., Kodumudi K.N., Reddy M.V., Kaliraj P. 2011. A combination of two Brugia malayi filarial vaccine candidate antigens (BmALT-2 and BmVAH) enhances immune responses and protection in jirds. Journal of Helminthology, 85, 442–452. DOI: org/10.1017/S0022149X10000799PubMedCrossRefGoogle Scholar
  6. Bergman P.J., Camps-Palau M.A., McKnight J.A., Leibman N.F., Craft D.M., Leung C., Liao J., Riviere I., Sadelain M., Hohenhaus A.E., Gregor P., Houghton A.N., Perales M.A., Wolchok J.D. 2006. Development of a xenogenetic DNA vaccine program for canine malignantmelanoma at the Animal Medical Center. Vaccine, 24, 4582–4585. DOI: 10.1016/j.vaccine. 005.08.027PubMedCrossRefGoogle Scholar
  7. Bolhassani A., Gholami E., Zahedifard F., Moradin N., Parsi P., Doustdari F., Seyed N., Papadopoulou B., Rafati S. 2011. Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice model. Experimental Parasitology, 128, 9–17. DOI: 10.1016/j.exppara.2011.01.012PubMedCrossRefGoogle Scholar
  8. Cao S., Mousa A.A., Aboge G.O., Kamyingkird K., Zhou M., Moumouni P.F.A., Terkawi M.A., Masatani T., Nishikawa Y., Suzuki H., Fukumoto S., Xuan X. 2013. Prime-boost vaccinationwith plasmid DNA followed by recombinant vaccinia virus expressing BgGARP induced a partial protective immunity to inhibit Babesia gibsoni proliferation in dogs. Acta Parasitologica, 58, 619–623. DOI: 10.2478/s11686-013-0183-1PubMedCrossRefGoogle Scholar
  9. Cannas A., Naguleswaran A., Muller N., Eperon S., Gottstein B., Hemphill A. 2003. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines. Parasitology, 126, 303–312PubMedCrossRefGoogle Scholar
  10. Chlichlia K., Bahgat M., Ruppel A., Schirrmacher V. 2001. DNA vaccination with asparaginyl endopeptidase (Sm32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice. Vaccine, 20, 439–447PubMedCrossRefGoogle Scholar
  11. Cruz Lança A.S., de Sousa K.P., Atouguia J., Prazeres D.M.F., Monteiro G.A., Silva M.S. 2011. Trypanosoma brucei: Immunisation with plasmid DNA encoding invariant surface glycoprotein gene is able to induce partial protection in experimental African trypanosomiasis. Experimental Parasitology, 127, 18–24. DOI: 10.1016/j.exppara.2010.06.017CrossRefGoogle Scholar
  12. Da’dara A.A., Skelly P.J., Fatakawadala M., Visovatti S., Eriksson E., Harn D.A. 2002. Comparative efficacy of the Schistosoma mansoni nucleic acid vaccine, Sm23, following microseeding or gene gun delivery. Parasite Immunology, 24, 179–187PubMedCrossRefGoogle Scholar
  13. Da’Dara A.A., Li Y.S., Xiong T., Zhou J., Williams G.M., McManus D.P., Fenge Z., Yu X.L., Gray D.J., Harn D.A. 2008. DNAbased vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine, 26, 3617–3625. DOI: 10.1016/j.vaccine.2008.04.080PubMedPubMedCentralCrossRefGoogle Scholar
  14. Dalton J.P., Robinson M.W., Mulcahy G., O’Neill S.M., Donnelly S. 2013. Immunomodulatory molecules of Fasciola hepatica. Candidates for both vaccine and immunotherapeutic development. Veterinary Parasitology, 195, 272–285. DOI: org/10.1016/j.vetpar.2013.04.008PubMedCrossRefGoogle Scholar
  15. Davidson A.H., Traub-Dargatz J.L., Rodeheaver R.M., Ostlund E.N., Pedersen D.D., Moorhead R.G., Stricklin J.B., Dewell R.D., Roach S.D., Long R.E., Albers S.J., Callan R.J., Salman M.D.2005. Immunologic responses to West Nile virus in vaccinated and clinically affected horses. Journal of the American Veterinary Medical Association, 226, 240–245. DOI: 10.2460/javma.2005.226.240PubMedCrossRefGoogle Scholar
  16. Dobano C., Rogers W.O., Gowda K., Doolan D.L. 2007. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines. Immunology Letters, 111, 92–102. DOI: 10.1016/j.imlet.2007.05.007PubMedCrossRefGoogle Scholar
  17. Du A., Wang S. 2005. Efficacy of a DNA vaccine delivered in attenuated Salmonella typhimurium against Eimeria tenella infection in chickens. International Journal forParasitology, 35, 777–785. DOI: 10.1016/j.ijpara.2005.03.005CrossRefGoogle Scholar
  18. Dunachie S.J., Walther M., Epstein J.E., Keating S., Berthoud T., Andrews, L., Andersen R.F., Bejon P., Goonetilleke N., Poulton I., Webster D.P., Butcher G., Watkins K., Sinden R.E., Levine GL., Richie, T.L., Schneider J., Kaslow D., Gilbert S.C., Carucci D.J., Hill A.V.S. 2006. A DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccine Encoding ThrombospondinRelated Adhesion Protein but Not Circumsporozoite Protein Partially Protects Healthy Malaria-Naive Adults against Plasmodium falciparum Sporozoite Challenge. Infection and Immunity, 74, 5933–5942. DOI: 10.1128/IAI.00590-06PubMedPubMedCentralCrossRefGoogle Scholar
  19. Espino A.M., Morales A., Delgado B., Rivera F.M., Figueroa O., Suárez E. 2010. Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct. Ethnicity & Disease, 20, S1-17-23Google Scholar
  20. Fukumoto F., Tamaki Y., Igarashi I., Suzuki H., Xuan X. 2009. Immunogenicity and growth inhibitory efficacy of the prime-boost immunization regime with DNA followed by recombinant vaccinia virus carrying the P29 gene of Babesia gibsoni in dogs. Experimental Parasitology, 123, 296–301. DOI: 10. 1016/j.exppara.2009.08.012PubMedCrossRefGoogle Scholar
  21. Garver K.A., LaPatra S.E., Kurath G. 2005. Efficacy of an infectious hematopoietic necrosis (IHN) virus DNA vaccine in Chinook Oncorhynchus tshawytscha and sockeye O. nerka salmon. Diseases of Aquatic Organisms, 64, 13–22. DOI: 10.3354/dao064013PubMedCrossRefGoogle Scholar
  22. Geriletu Xu L., Xurihu Li X. 2011. Vaccination of chickens with DNA vaccine expressing Eimeria tenella MZ5-7 against coccidiosis. Veterinary Parasitology, 177, 6–12. DOI: 10.1016/j.vetpar.2010.11.041PubMedCrossRefGoogle Scholar
  23. Han K., Xu L., Yan R., Song X., Li X. 2012. Vaccination of goats with glyceraldehyde-3-phosphate dehydrogenase DNA vaccine induced partial protection against Haemonchus contortus. Veterinary Immunology and Immunopathology, 149, 177–185. DOI:10.1016/j.vetimm.2012.06.016. Epub 2012 Jun 19PubMedCrossRefGoogle Scholar
  24. He S., Yang L., Lv Z., Hu W., Cao J., Wei J., Sun X., Zheng H., Wu Z. 2010. Molecular and functional characterization of a mortalin-like protein from Schistosoma japonicum (SjMLP/hsp70) as a member of the HSP70 family. Parasitology Research, 107, 955–966. DOI: 10.1007/s00436-010-1960-5PubMedCrossRefGoogle Scholar
  25. Hezarjaribi H.Z., Ghaffarifar F., Dalimi F., Sharifi Z., Jorjani O. 2013. Effect of IL-22 on DNA vaccine encoding LACK gene of Leishmania major in BALB/c mice. Experimental Parasitology, 134, 341–348. DOI: org/10.1016/j.exppara.2013.03.012PubMedCrossRefGoogle Scholar
  26. Hiszczynska-Sawicka E., Olędzka G., Holec-Gąsior L., Li H., Xua, J.B. Sedcole R., Kur J., Bickerstaffe R., Stankiewicz M. 2011a. Evaluation of immune responses in sheep inducedby DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii. Veterinary Parasitology, 177, 281–289. DOI: 10.1016/j.vetpar.2010. 11.047PubMedCrossRefGoogle Scholar
  27. Hiszczynska-Sawicka E., Li H., Xua J.B., Holec-Gąsior L., Kur J., Sedcole R., Bickerstaffe R., Stankiewicz M. 2011b. Modulation of immune response to Toxoplasma gondii in sheep by immunization with a DNA vaccine encoding ROP1 antigen as a fusion protein with ovine CD154. Veterinary Parasitology, 183, 72–78. DOI: 10.1016/j.vetpar.2011.06.010PubMedCrossRefGoogle Scholar
  28. Januszkiewicz K. 2010. Optimalization of vaccination against Fasciola hepatica infections using cDNA encoding for selected fluke antigens and specific for the host species CTLA-4 molecule. PhD Thesis. Witold Stefański Institute of Parasitology Polish Academy of Sciences, Warsaw, PolandGoogle Scholar
  29. Jaros S., Jaros D., Wesolowska A., Zygner W., Wedrychowicz H. 2010. Blocking Fasciola hepatica’s energy metabolism - a pilot study of vaccine potential of a novel gene - phosphoglycerate kinase. Veterinary Parasitology, 172, 229–237. DOI: 10.1016/j.vetpar.2010.05.008PubMedCrossRefGoogle Scholar
  30. Jayaraj R., Piedrafita D., Spithill T., Smooker P. 2012. Evaluation of the immune responses induced by four targeted DNA vaccines encoding the juvenile liver fluke antigen, cathepsin B in a mouse model. Genetic Vaccines and Therapy 2012, 10, 2–7, http://www.gvt-journal.com/content/10/1/7CrossRefGoogle Scholar
  31. Jenkins M., Parker C., Tuo W., Vinyard B., Dubey J.P. 2004. Inclusion of CpG adjuvant with plasmid DNA coding for NcGRA7 improves protection against congenital neosporosis. Infection and Immunity, 72, 1817–1819, DOI: 10.1128/IAI.72.3.1817-1819.2004Google Scholar
  32. Kalyanasundaram R., Balumuri P. 2011. Multivalent vaccine formulation with BmVAL-1 and BmALT-2 confer significant protection against challenge infections with Brugia malayi in mice and jirds. Research and Reports in Tropical Medicine 2011, 45–56. DOI: 10.2147/RRTMS13679Google Scholar
  33. Kennedy N.J., Spithill T.W., Tennent J., Wood P.R., Piedrafita D. 2006. DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy. Vaccine, 24, 970–979. DOI: 10.1016/j.vaccine.2005.08.076PubMedCrossRefGoogle Scholar
  34. Kimani D., Jagne Y.J., Cox M., Kimani E., Bliss C.M., Gitau, E., Ogwang C., Afolabi M.O., Bowyer G., Collins K.A. et al. 2014. Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations. Molecular Therapy, 22, 1992–2003. DOI: 10.1038/mt.2014.109.PubMedPubMedCentralCrossRefGoogle Scholar
  35. Klinman D.M., Yamshchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. Journal of Immunology, 158, 3635-3642Google Scholar
  36. Kofta W., Wędrychowicz H. 2001. c-DNA vaccination against parasitic infections: advantages and disadvantages. Veterinary Parasitology 94; 243–247, DOI: 10.1016/SO304-4017(01) 00478-2Google Scholar
  37. Kurup S.P., Tewari A.K. 2012. Induction of protective immune response in mice by a DNA vaccine encoding Trypanosoma evansi beta tubulin gene. Veterinary Parasitology, 187, 9–16. DOI: 10.1016/j.vetpar.2012.01.009PubMedCrossRefGoogle Scholar
  38. Lee J.S., Kim I.S., Sohn W.M., Lee J., Yong T.S. 2006a. A DNA vaccine encoding a fatty acid binding protein of Clonorchis sinensis induces protective immune response in Sprague-Dawley rats. Scandinavian Journal of Immunology, 63, 169–176 DOI: 10.1111/j.1365-3083.2006.01721.xPubMedCrossRefGoogle Scholar
  39. Lee J., Kim I.S., Sohn W., Lee J., Yong T. 2006.b Vaccination with DNA encoding cysteine proteinase confers protective immune response to rats infected with Clonorchis sinensis. Vaccine, 24, 2358–2366PubMedCrossRefGoogle Scholar
  40. Levine M.M. and Sztein M.B. 2004. Vaccine development strategies for improving immunization: The role of modern immunology. Nature Immunology, 5, 460–464. DOI: 10.1038/ni0504-460PubMedCrossRefGoogle Scholar
  41. Li M., Lei J., WangT., Lu S., Guan F., Liu W., Li Y. 2011. Cimetidine enhances the protective effect of GST DNA vaccine against Schistosoma japonicum. Experimental Parasitology 128, 427–432. DOI: 10.1016/j.exppara.2011.05.012PubMedCrossRefGoogle Scholar
  42. Liddell S., Parker C., Vinyard B., Jenkins M., Dubey J.P. 2003. Immunization of mice with plasmid DNA coding for NcGRA7 or NcsHSP33 confers partial protection against vertical transmission of Neospora caninum. Journal of Parasitology, 89, 496–500. DOI: org/10.1645/GE-2969PubMedCrossRefGoogle Scholar
  43. Liu, M.A. 2010. DNA vaccines: An historical perspective and view to the future. Immunological Reviews, 239, 62–84. DOI: org/10.1111/j.1600-065X.2010.00980.xCrossRefGoogle Scholar
  44. Liu Q., Shang L., Jin H., WeiF., Zhu Q., Gao H. 2010. The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18. Research in Veterinary Science, 89, 93–97. DOI: 10.1016/j.rvsc.2010.01.007PubMedCrossRefGoogle Scholar
  45. Mancini-Bourgine M., Fontaine H., Brechot C., Pol S., Michel M.L. 2006. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Vaccine, 24, 4482–4489. DOI: 10.1016/j.vaccine.2005.08.013PubMedCrossRefGoogle Scholar
  46. Masih S., Arora S.K., Vasishta R.K. 2011. Efficacy of Leishmania donovani ribosomal P1 gene asDNA vaccine in experimental visceral leishmaniasis. Experimental Parasitology, 129, 55–64. DOI: 10.1016/j.exppara.2011.05.014PubMedCrossRefGoogle Scholar
  47. Martin J.E., Louder M.K., Holman L.A., Gordon I.J., Enama M.E, Larkin B.D. et al. 2008 A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial. Vaccine, 26, 6338–6343. DOI: 10.1016/j.vaccine.2008.09.026PubMedPubMedCentralCrossRefGoogle Scholar
  48. McCullers J.A. 2007. Evolution, benefits, and shortcomings of vaccine management. Journal of Managed Care Pharmacy, 13, S2–S6PubMedCrossRefGoogle Scholar
  49. Mc Neilly T.N., Nisbet A.J. 2014. Immune modulation by helminth parasites of ruminants: implications for vaccine development and host immune competence. Parasite, 21, 51–62. DOI: 10.1051/parasite/2014051CrossRefGoogle Scholar
  50. Molloy M., Bouladoux N., Belkaid Y. 2012. Intestinal microbiota: shaping local and systemic immune responses. Seminar in Immunology, 24, 51–55. DOI: 10.1016/j.smim.2011CrossRefGoogle Scholar
  51. Nielsen H.V., Di Cristina M., Beghetto E., Spadoni A., Petersen E., Gargano N. 2006. Toxoplasma gondii: DNA vaccination with bradyzoite antigens induces protective immunity in mice against oral infection with parasite cysts. Experimental Parasitology, 112, 274–279. DOI: 10.1016/j.exppara.2005. 11.009PubMedCrossRefGoogle Scholar
  52. Payette P.J., Weeratna R.D., McCluskie M.J., Davis H.L. 2001. Immunemediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms. Gene Therapy, 8, 1395–1400. DOI: org/10.1038/sj.gt.3301534PubMedCrossRefGoogle Scholar
  53. Person R., Bodles-Brakhop A.M., Pope M.A., Brown P.A., Khan A.S., Draghia-Akli R. 2008. Growth hormone-releasing hormone plasmid treatment by electroporation decreases offspring mortality over three pregnancies. Molecular Therapy, 16, 1891–1897. DOI: 10.1038/mt.2008.178PubMedCrossRefGoogle Scholar
  54. Qu D., Han J., Du A. 2013. Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice Parasitology Research, 112, 2593–2599. DOI 10.1007/s00436-013-3425-0PubMedGoogle Scholar
  55. Rafati S., Zahedifard F., Azari M.K., Taslimi Y., Taheri T. 2008. Leishmania infantum: Prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice. Experimental Parasitology, 118, 393–401. DOI: 10.1016/j.exppara.2007.10.004PubMedCrossRefGoogle Scholar
  56. Rainczuk A., Scorza T., Spithill T.W., Smooker P.M. 2004. A bicistronic DNA vaccine containing Apical Membrane Antigen 1 and Merozoite Surface Protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria. Infection and Immunity, 72, 5565–5573. DOI: 10.1128/IAI.72.10. 5565-5573.2004PubMedPubMedCentralCrossRefGoogle Scholar
  57. Rathaur S., Yadav M., Gupta S., Anandharaman V., Reddy M.V. 2008. Filarial glutathione-S-transferase: a potential vaccine candidate against lymphatic filariasis. Vaccine, 26, 4094–4100. DOI: 10.1016/j.vaccine.2008.03.099PubMedCrossRefGoogle Scholar
  58. Robinson M.W., Dalton J.P., O’Brien B.A., Donnelly S. 2013. Fasciola hepatica: The therapeutic potential of a worm secretome. International Journal for Parasitology, 43, 283–291. ttp://dx.doi.org/10.1016/j.ijpara.2012.11.004PubMedCrossRefGoogle Scholar
  59. Saade F., Petrovsky N. 2012. Technologies for enhanced efficacy of DNA vaccines. Expert Review of Vaccines, 11, 189–209. DOI: 10.1586/erv.11.188PubMedPubMedCentralCrossRefGoogle Scholar
  60. Sato Y, Roman M., Tighe H., Lee D., Corr M., Nguyen M., Silverman G.J., Lotz M., Carson D.A., Raz E. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science, 273, 352–354PubMedCrossRefGoogle Scholar
  61. Shah M.A.A., Yan R., Xu L., Song X., Li X. 2010. A recombinant DNA vaccine encoding Eimeria acervulina cSZ-2 induces immunity against experimental E. tenella infection. Veterinary Parasitology, 169, 185–189. DOI: 10.1016/j.vetpar.2009.12.035PubMedCrossRefGoogle Scholar
  62. Shah M.A.A., Song X., Xu L., Yan R., Li X. 2011. Construction of DNA vaccines encoding Eimeria acervulina cSZ-2 with chicken IL-2 and IFN-c and their efficacy against poultry coccidiosis. Research in Veterinary Science, 90, 72–77. DOI: 10.1016/j.rvsc.2010.05.003PubMedCrossRefGoogle Scholar
  63. Shi W., Liu Q., Zhang J., Sun J., Jiang X., Geng J., Wang F., Xiao Y., Li H., Zhao X. 2014. Co-expression of EtMic2 protein and chicken interleukin-18 for DNA vaccine against chicken coccidiosis. Research in Veterinary Science, 97, 64–70. DOI: org/10.1016/j.rvsc.2014.05.001PubMedCrossRefGoogle Scholar
  64. Smooker P.M., Kennedy N.J., Steeper K.R., Christopoulos H., Spithill T.W. 2001. Fasciola: Kinetics and quality of humoral responses to fatty acid binding protein and cathepsin l following delivery as DNA vaccines in mice. Experimental Parasitology, 97, 154–160, DOI: 10.1006/expr.2001.4601PubMedCrossRefGoogle Scholar
  65. Song X., Xu L., Yan R., Huang X., Shah M.A.A., Li X. 2009. The optimal immunization procedure of DNA vaccine pcDNA-TA4-IL-2 of Eimeria tenella and its cross-immunity to Eimeria necatrix and Eimeria acervulina. Veterinary Parasitology 159, 30–36. DOI: 10.1016/j.vetpar.2008.10.015PubMedCrossRefGoogle Scholar
  66. Song H., Yan R., Xu L., Song X., Shah M.A.A., Zhu H., Li X., 2010. Efficacy of DNA vaccines carrying Eimeria acervulina lactate dehydrogenase antigen gene against coccidiosis. Experimental Parasitology, 126, 224–231. DOI: 10.1016/j.exppara.2010.05.015PubMedCrossRefGoogle Scholar
  67. Song H., Qiu B., Yan R Xu L., Song X., Li X. 2013. The protective efficacy of chimeric SO7/IL-2 DNA vaccine against coccidiosis in chickens Research in Veterinary Science, 94, 562–567. DOI: org/10.1016/j.rvsc.2012.11.006PubMedCrossRefGoogle Scholar
  68. Schneider J., Langermans J.A., Gilbert S.C., Blanchard T.J., Twigg S., Naitza S., Hannan C.M., Aidoo M., Crisanti A., Robson K.J. et al. A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees. Vaccine 2001, 19, 4595–4602PubMedCrossRefGoogle Scholar
  69. Sun W., Song X., Yan R., Xu L., Li X. 2011. Vaccination of goats with a glutathione peroxidase DNA vaccine induced partial protection against Haemonchus contortus infection. Veterinary Parasitology 182, 239–247. DOI: 10.1016/j.vetpar.2011.05.024PubMedCrossRefGoogle Scholar
  70. Thirugnanam S., Pandiaraja P., Ramaswamy K., Murugan V., Gnanasekar M., Nanadakumar K., Reddy M.V., Kaliraj P. 2007. Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model. Experimental Parasitology, 116, 483–491. DOI: 10.1016/j.exppara.2007.02.017PubMedPubMedCentralCrossRefGoogle Scholar
  71. Van Riet E., Hartgers F.C., Yazdanbakhsh M. 2007. Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology, 212, 6, 475–490. DOI: 10.1016/j.imbio.2007.03.009CrossRefGoogle Scholar
  72. Vaughan E.E., Dean D.A. 2006. Intracellular trafficking of plasmids during transfection is mediated by microtubules. Molecular Therapy, 13, 422–428. DOI: org/10.1016/j.ymthe. 2005.10.004PubMedCrossRefGoogle Scholar
  73. Waine G.J., Alarcon J.B., McManus D.P. 2002. Genetic immunization of mice with DNA encoding the 23 kDa transmembrane surface protein of Schistosoma japonicum (Sj23) induces antigen-specific immunoglobulin G antibodies. Parasite Immunology, 1999, 21, 377–381CrossRefGoogle Scholar
  74. Wang H., He S., Yao Y., Cong H., Zha H., Li T., Zhu X. 2009. Toxoplasma gondii: Protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice. Experimental Parasitology, 122, 226–232. DOI: 10.1016/j.exppara.2009.04.002PubMedCrossRefGoogle Scholar
  75. Wahren W., Liu M.A. 2014. DNA vaccines: recent developments and the future. Vaccines, 2, 785–796. DOI: 10.3390/vaccines 2040785Google Scholar
  76. Wesołowska A., Norbury L., Januszkiewicz K., Jedlina L., Jaros S., Zawistowska-Deniziak A., ZygnerW., Wędrychowicz H. 2013. Evaluation of the immune response of male and female rats vaccinated with cDNA encoding a cysteine proteinase of Fasciola hepatica (FhPcW1). Acta Parasitologica, 58, 198–206. DOI:10.2478/s11686-013-0120-3PubMedCrossRefGoogle Scholar
  77. Wedrychowicz H., Szymanski P., Panasiuk L.J., Bienkowska-Szewczyk K. 2002. Humoral immune response of rats vaccinated with cDNA or protein form of glutathione-S-transferase of Fasciola hepatica to infection with metacercariae of the fluke. Helminthologia, 39, 127–133Google Scholar
  78. Wędrychowicz H., Lamparska M., Kęsik M., Kotomski G., Mieszczanek J., Jedlina-Panasiuk L., Płucienniczak A. 2003. The immune response of rats to vaccination with cDNA or protein forms of the cysteine proteinase of Fasciola hepatica. Veterinary Immunology and Immunopathology, 94, 83–93. DOI: 10.1016/S0165-2427(03)00085-0PubMedCrossRefGoogle Scholar
  79. Williams J.A. 2013. Vector Design for Improved DNA Vaccine Efficacy, Safety and Production. Vaccines, 1, 225–249. DOI: 10.3390/vaccines1030225PubMedPubMedCentralCrossRefGoogle Scholar
  80. Wiśniewski M., Jaros S., Bąska P., Capello M., Wędrychowicz H. 2013. Ancylostoma ceylanicum metalloprotease 6 DNA vaccination induces partial protection against hookworm challenge infection. Acta Parasitologica 58, 376–383. DOI: 10.2478/s11686-013-0151-9PubMedCrossRefGoogle Scholar
  81. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. 1990. Direct gene transfer into mouse muscle in vivo. Science, 247, 1465–1468. DOI: org/10.1126/science. 1690918PubMedCrossRefGoogle Scholar
  82. Xiang W., Qiong Z., Li-peng L., Kui T., Jian-wu G., Heng-ping S. 2009. The location of invasion-related protein MIC3 of Toxoplasma gondii and protective effect of its DNA vaccine in mice. Veterinary Parasitology, 166, 1–7. DOI: 10.1016/j.vetpar. 2009.08.014PubMedCrossRefGoogle Scholar
  83. Xu Q., Song X., Xu L., Yan R., Shah M., Li X., 2008. Vaccination of chickens with a chimeric DNA vaccine encoding Eimeria tenella TA4 and chicken IL-2 induces protective immunity against coccidiosis. Veterinary Parasitology, 156, 319–323. DOI: 10.1016/j.vetpar.2008.05.025PubMedCrossRefGoogle Scholar
  84. Xue M., He S., Zhang J., Cui Y., Yao Y., Wang H. 2008a. Comparison of cholera toxin A2/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine. Experimental Parasitology, 119, 352–357, DOI: 10.1016/j.exppara.2008.03.005PubMedCrossRefGoogle Scholar
  85. Xue M., He S., Zhang J., Cui Y., Yao Y., Wang H. 2008b. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii. Parasitology International 57, 424–429. DOI: 10.1016/j.parint.2008.05.001PubMedCrossRefGoogle Scholar
  86. Yamakami K., Akao S., Sato M., Nitta Y., Miyazaki J., Tadakuma T. 2001. A single intradermal administration of soluble leishmanial antigen and plasmid expressing interleukin-12 protects BALB c mice from Leishmania major infection. Parasitology International, 50, 81–91PubMedCrossRefGoogle Scholar
  87. Yan H., Yuan Z., Petersen E., Zhang X., Zhou D., Liu Q., He Y., Lin R., Xu M., Chen X., Zhong X., Zhu X. 2011. Toxoplasma gondii: Protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1. Experimental Parasitology, 128, 38–43. DOI: 10.1016/j.exppara.2011.02.005PubMedCrossRefGoogle Scholar
  88. Yan R., Sun W., Song X., Li X. 2013. Vaccination of goats with DNA vaccine encoding Dim-1 induced partial protection against Haemonchus contortus: A preliminary experimental study Research in Veterinary Science, 95, 189–199. DOI: org/10.1016/j.rvsc.2013.02.020PubMedCrossRefGoogle Scholar
  89. You Z., Huang X., Hester J., Toh H.C., Chen S.Y. 2001. Targeting dendritic cells to enhance DNA vaccine potency. Cancer Research, 61, 3704–3711PubMedGoogle Scholar
  90. Yu Q., Li J., Zhang X., Gong P., Zhang P., Li S., Wang H. 2010. Induction of immune responses in mice by a DNA vaccine encoding Cryptosporidium parvum Cp12 and Cp21 and its effect against homologous oocyst challenge. Veterinary Parasitology. 172, 1–7. DOI: 10.1016/j.vetpar.2010.04.036PubMedCrossRefGoogle Scholar
  91. Yu L., Yamagishi J., Zhang S., Jin Ch., Aboge O.G., Zhang H., Zhang G., Tanaka T., Fujisaki K., Nishikawa Y., Xuan X. 2012. Protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing TgAMA1 as vaccines against Toxoplasma gondii infection in mice. Parasitology International, 61, 481–486. DOI: 10.1016/j.parint.2012.04.001PubMedCrossRefGoogle Scholar
  92. Yuan H., You-en S., Long-jiang Y., Xiao-hua Z., Liu-zhe L., Cash M., Lu Z., Zhi L., Deng-xin S. 2006. Studies on the protective immunity of Schistosoma japonicum bivalent DNA vaccine encoding Sj23 and Sj14. Experimental Parasitology, 115, 379–386. DOI: 10.1016/j.exppara.2006.09.022PubMedCrossRefGoogle Scholar
  93. Zhao Y., Bao Y., Zhang L., Chang L., Jiang L., Liu Y., Zhang L., Qin J. 2013. Biosafety of the plasmid pcDNA3-1E of Eimeria acervulina in chicken. Experimental Parasitology, 133, 231–236, DOI: org/10.1016/j.exppara.2012.11.026PubMedCrossRefGoogle Scholar
  94. Zhao G., Yan R., Muleke C.I., Sun Y., Xu L., Li X. 2012. Vaccination of goats with DNA vaccines encoding H11 and IL-2 induces partial protection against Haemonchus contortus infection. Veterinary Journal, 191, 94–100. DOI: 10.1016/j.tvjl.2010.12.023. Epub 2011 Feb 16.CrossRefGoogle Scholar
  95. Zhu Y., Lu F., Dai Y., Wang X., Tang J., Zhao S., Zhang Ch., Zhang H., Lu S., Wang S. 2010. Synergistic enhancement of immunogenicity and protection in mice against Schistosoma japonicum with codon optimization and electroporation delivery of SjTPI DNA vaccines. Vaccine, 28, 5347–5355. DOI: 10.1016/j.vaccine.2010.05.017PubMedCrossRefGoogle Scholar
  96. Zhu L., Liu H., Lu M., Long Q., Shi Y., Yu L. 2011. Construction, purification, and evaluation of multivalent DNA vaccine against Schistosoma japonicum Parasitology Research, 108, 115–121. DOI: 10.1007/s00436-010-2040-6PubMedCrossRefGoogle Scholar

Copyright information

© Witold Stefański Institute of Parasitology, Polish Academy of Sciences 2015

Authors and Affiliations

  1. 1.Department of Molecular Biology, Laboratory of Molecular Parasitology, W. Stefański Institute ParasitologyPolish Academy of SciencesWarsawPoland

Personalised recommendations